Invivosciences’ Co-founder, Elliot L. Elson, PhD, has been elected to the Nation Academy of Sciences, one of the highest honors that can be awarded to a U.S. scientist or engineer. Learn more about Elliot and his election in this news release.
InvivoSciences had the honor of speaking about the company on the Annie Jennings PR’s AuthoreExpertWire Podcast. Listen to it here to learn more about InvivoSciences and precision medicine for heart failure to keep hearts beating:
InvivoSciences participated in Life Science Nation’s Digital Redefining Early Stage Investments (RESI) September Conference this past week. We are excited to announce that we won the second place as one of the Top 3 Winners of the Innovation Challenge Competition. Through the challenge, our company had a dedicated page featuring a virtual poster, short pitch, and…
InvivoSciences has been selected to participate and present at the Digital RESI September 2020 conference as an NIH delegated company; we have also been selected to participate in their VC partnering program. Let’s meet at RESI!
InvivoSciences has been selected as one of the finalist among thousands of global entries to participate in MassChallenge Boston’s 2020 Accelerator. Learn more about MassChallenge Boston’s 2020 program and see the rest of the cohort here. About MassChallenge MassChallenge is a global network of zero-equity startup accelerators. Headquartered in the United States with locations in…
Invivosciences, Inc has been honored with Global Health and Pharma’s 2020 Biotechnology Award for Best Tissue-Based Assay R&D Engineering Company. We would like to graciously accept this award. And thank GHP for their selection.
Invivosciences, Inc. is honored to work with COVID-19 Task Force to be part of solutions. We are dedicated to innovate and support researchers, medical teams and drug developers world-wide by providing uninterrupted contract research services. Learn more about the COVID-19 Task Force here.
InvivoSciences has been given the honor to attend and present at the Bio 2020 Annual Meeting in San Diego, California from June 8-11, 2020. InvivoSciences is selected to participate under NIH Innovation Zone and will deliver a company presentation. Learn more about BIO Digital here.
InvivoSciences was recently featured in the February 2020 issue of Brava Magazine. You can read the article below. Previous Next
Dr. Lenka Fedorkova InvivoSciences, Inc. is delighted to announce the joining of Dr. Fedorkova to the business team as Strategic Adviser. She is currently CEO/ Founder of bioPrime, LLC, Director Corporate Development at AfaSci Research Laboratories, Inc., and Board Member for Yale Entrepreneurial Institute. She was formerly Executive Manager of SBIR/STTR Programs at the National…